Tamon Nagashima

Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study

Takeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima et al. · Hepatology Research · 2019 · 36 citations

The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study

Takeshi Hatanaka, Atsushi Naganuma, Mitsuhiko Shibasaki et al. · Oncology · 2020 · 24 citations

Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression

Atsushi Hiraoka, Takashi Kumada, Takeshi Hatanaka et al. · Hepatology Research · 2021 · 23 citations

Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment

Takeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima et al. · Cancers · 2020 · 21 citations · Full text

Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study

Takeshi Hatanaka, Satoru Kakizaki, Daisuke Uehara et al. · Internal Medicine · 2019 · 15 citations · Full text